Dan Goldstein, Vice President, Corporate Controller and Principal Accounting Officer will leave Haemonetics Corporation on August 9, 2022. The company is grateful for Mr. Goldstein's meaningful contributions during his time at the Company. Mr. Goldstein will remain in his current role while the company conducts a search for his successor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.5 USD | +0.56% | +9.42% | +7.01% |
04/04 | Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge | MT |
04/04 | Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.01% | 4.62B | |
-2.54% | 187B | |
-1.85% | 106B | |
-4.26% | 66.9B | |
+1.39% | 49.45B | |
+16.82% | 48B | |
+5.08% | 40.84B | |
+3.49% | 26.48B | |
+0.65% | 26.25B | |
+16.96% | 24.62B |
- Stock Market
- Equities
- HAE Stock
- News Haemonetics Corporation
- Haemonetics Corporation Announces Retirement of Dan Goldstein as Vice President, Corporate Controller and Principal Accounting Officer, Effective August 9, 2022